Vaccitech

Two of the scientists behind Britain’s AstraZeneca jab could both make £26million today as the tech firm that developed it hits the US stock market. Oxford professors Sarah Gilbert and Adrian Hill both own 5.2 per cent of Vaccitech, which will later float on America’s Nasdaq exchange. The pair are alongside other scientists and investors who … Read more

Two of the scientists behind Britain’s AstraZeneca jab could both make £26million today as the tech firm that developed it hits the US stock market. Oxford professors Sarah Gilbert and Adrian Hill both own 5.2 per cent of Vaccitech, which will later float on America’s Nasdaq exchange. The pair are alongside other scientists and investors who … Read more